Sarthak Metals Limited — PPTs, 13-11-2025: Investor Presentation

Sarthak Metals Limited's board has approved the financial results for the quarter and half-year ended September 30, 2025.

**Business Performance:** Q2 FY26 revenue saw a dip to Rs 36.31 Cr, down from Rs 45.72 Cr in Q2 FY25, with net profit also softening to Rs 0.76 Cr from Rs 0.83 Cr. For the first half (H1) of FY26, total revenue reached Rs 82.53 Cr, yielding a profit of Rs 1.82 Cr. EPS for Q2 was Rs 0.57. The balance sheet showed a significant drop in cash and equivalents to Rs 0.19 Cr, coupled with an increase in current borrowings to Rs 2.85 Cr.

**Growth Drivers/Strategy:** The company is charting a new course with a strategic diversification into biotechnology. This involves amending its main object clause to include areas like bio-based chemicals, pharmaceuticals, and biological formulations, targeting "emerging growth sectors" with "significant commercial potential."

**Recent Developments:** Shareholders will be asked to approve this object clause amendment and the re-appointment of Independent Director Mr. Sunil Dutt Bhatt for a second five-year term via postal ballot.

**Management Outlook:** This strategic pivot reflects management's commitment to future growth and exploring new opportunities beyond its existing Cored Wires business.